Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qianyi Zhang
Institution:
Flatiron Health (United States)
Observed institution:
Flatiron Health (United States)
ORCID:
0000-0002-7850-6701
Observed ORCID:
0000-0002-7850-6701
OpenAlex ID:
A5057320110
Validation analysis of a composite real‐world mortality endpoint for patients with cancer in the United States
2021
·
Qianyi Zhang
, Anala Gossai
, et al.
·
Health Services Research
·
176
PDF
Analysis of Real-World Progression and Insufficient Response Variables and Related Endpoints Among Patients with Non-Hodgkin Lymphoma
2025
·
Madeline Richey
, Christina Fullerton
, et al.
·
Advances in Therapy
·
1
SA59 Laboratory Testing Patterns in Patients With Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Country Electronic Health Record Study From the UK, Germany, and Japan
2025
·
Elsie Horne
, Patrycja Pluta
, et al.
·
Value in Health
EPH143 Incidence of Neutropenia Adverse Events Identified in Electronic Healthcare Records Among Initiators of CDK4/6 Inhibitors With Advanced Breast Cancer in the UK
2025
·
Lockwood Taylor
, Elsie Horne
, et al.
·
Value in Health
Show more works
View as search
Works count:
4
Citation count:
181
H-index:
1
I10-index:
1
Year
Topic
Type